BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen XL, Mao JW, Wang YD. Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future. World J Gastrointest Pathophysiol 2020; 11(3): 43-56 [PMID: 32435521 DOI: 10.4291/wjgp.v11.i3.43]
URL: https://www.wjgnet.com/1007-9327/full/v11/i3/43.htm
Number Citing Articles
1
Alvise Sernicola, Anna Colpo, Anca Irina Leahu, Mauro Alaibac. Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?Medicina 2022; 58(10): 1398 doi: 10.3390/medicina58101398
2
Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Salim Surani. Apheresis: A cell-based therapeutic tool for the inflammatory bowel diseaseWorld Journal of Clinical Cases 2022; 10(21): 7195-7208 doi: 10.12998/wjcc.v10.i21.7195
3
Giorgos Bamias, Evanthia Zampeli, Eugeni Domènech. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresisExpert Review of Gastroenterology & Hepatology 2022; 16(8): 721 doi: 10.1080/17474124.2022.2100759
4
Laura Gnesotto, Guido Mioso, Mauro Alaibac. Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)Experimental and Therapeutic Medicine 2022; 24(2) doi: 10.3892/etm.2022.11463